Top

Published in:

01-08-2018 | Review

Transcatheter aortic valve implantation in Germany

Authors: Won-Keun Kim, Christian W. Hamm

Published in: Clinical Research in Cardiology | Special Issue 2/2018

Abstract

Over the past years, there has been a tremendous evolution of transcatheter aortic valve implantation (TAVI) that turned a novel revolutionary approach to a mature concept. Peri-procedural complications and mortality rates have markedly decreased; hence, TAVI became an integral component of the treatment strategy for patients with severe aortic stenosis and now is the preferred therapy in elderly patients with moderate to high or prohibitive operative risk. This successful development would not have been possible without the joint efforts of clinicians, scientists, engineers, and many others from around the world. In this context, Germany has been one of the forerunners in implanting transcatheter heart valves, as evidenced not only by the high numbers of procedures, but in particular by some individual pioneering achievements. Here, we picture German contributions in the field of TAVI that had impact on clinical practice, including first-in-man experience, CE mark trials, randomized studies, large registries, and other procedurally relevant aspects.

Frerker C, Bestehorn K, Schluter M et al (2017) In-hospital mortality in propensity-score matched low-risk patients undergoing routine isolated surgical or transfemoral transcatheter aortic valve replacement in 2014 in Germany. Clin Res Cardiol 106(8):610–617. https://doi.org/10.1007/s00392-017-1097-y CrossRefPubMed

Gaede L, Blumenstein J, Liebetrau C et al (2017) Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J. https://doi.org/10.1093/eurheartj/ehx688 PubMedCentralCrossRef

Gaede L, Blumenstein J, Kim WK et al (2017) Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair. Clin Res Cardiol 106(6):411–419. https://doi.org/10.1007/s00392-016-1070-1 CrossRefPubMed

Walther T, Falk V, Borger MA et al (2007) Minimally invasive transapical beating heart aortic valve implantation–proof of concept. Eur J Cardiothorac Surg 31(1):9–15. https://doi.org/10.1016/j.ejcts.2006.10.034 CrossRefPubMed

Walther T, Simon P, Dewey T et al (2007) Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 116(11 Suppl):I240-245. https://doi.org/10.1161/CIRCULATIONAHA.106.677237 CrossRef

Walther T, Falk V, Dewey T et al (2007) Valve-in-a-valve concept for transcatheter minimally invasive repeat xenograft implantation. J Am Coll Cardiol 50(1):56–60. https://doi.org/10.1016/j.jacc.2007.03.030 CrossRefPubMed

Walther T, Falk V, Borger MA et al (2009) Transapical aortic valve implantation in patients requiring redo surgery. Eur J Cardiothorac Surg 36(2):231–234. https://doi.org/10.1016/j.ejcts.2009.02.016 (discussion 234–235)CrossRefPubMed

Kempfert J, Rastan AJ, Mohr FW et al (2011) A new self-expanding transcatheter aortic valve for transapical implantation—first in man implantation of the JenaValve. Eur J Cardiothorac Surg 40(3):761–763. https://doi.org/10.1016/j.ejcts.2010.12.063 PubMedCrossRef

Falk V, Walther T, Schwammenthal E et al (2011) Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur Heart J 32(7):878–887. https://doi.org/10.1093/eurheartj/ehq445 CrossRefPubMed

10.

Kempfert J, Treede H, Rastan AJ et al (2013) Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA): 6-month outcomes. Eur J Cardiothorac Surg 43(1):52–56. https://doi.org/10.1093/ejcts/ezs139 (discussion 57)CrossRefPubMed

11.

Grube E, Laborde JC, Gerckens U et al (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114(15):1616–1624. https://doi.org/10.1161/CIRCULATIONAHA.106.639450 CrossRefPubMed

12.

Grube E, Schuler G, Buellesfeld L et al (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50(1):69–76. https://doi.org/10.1016/j.jacc.2007.04.047 CrossRefPubMed

13.

Wenaweser P, Buellesfeld L, Gerckens U et al (2007) Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system. Catheter Cardiovasc Interv 70(5):760–764. https://doi.org/10.1002/ccd.21300 CrossRefPubMed

14.

Naber CK, Ghanem A, Abizaid AA et al (2012) First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 8(1):43–50. https://doi.org/10.4244/EIJV8I1A8 CrossRefPubMed

15.

Abdel-Wahab M, Mehilli J, Frerker C et al (2014) Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311(15):1503–1514. https://doi.org/10.1001/jama.2014.3316 CrossRefPubMed

16.

Abdel-Wahab M, Neumann FJ, Mehilli J et al (2015) 1-year outcomes after transcatheter aortic valve replacement with balloon-expandable versus self-expandable valves: results from the CHOICE Randomized Clinical Trial. J Am Coll Cardiol 66(7):791–800. https://doi.org/10.1016/j.jacc.2015.06.026 CrossRefPubMed

17.

Haussig S, Mangner N, Dwyer MG et al (2016) Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI Randomized Clinical Trial. JAMA 316(6):592–601. https://doi.org/10.1001/jama.2016.10302 CrossRefPubMed

18.

Beckmann A, Hamm C, Figulla HR et al (2012) The German aortic valve registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg 60(5):319–325. https://doi.org/10.1055/s-0032-1323155 CrossRefPubMed

19.

Hamm CW, Mollmann H, Holzhey D et al (2014) The German aortic valve registry (GARY): in-hospital outcome. Eur Heart J 35(24):1588–1598. https://doi.org/10.1093/eurheartj/eht381 CrossRefPubMed

20.

Walther T, Hamm CW, Schuler G et al (2015) Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol 65(20):2173–2180. https://doi.org/10.1016/j.jacc.2015.03.034 CrossRefPubMed

21.

Eggebrecht H, Bestehorn M, Haude M et al (2016) Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J 37(28):2240–2248. https://doi.org/10.1093/eurheartj/ehw190 CrossRefPubMed

22.

Eggebrecht H, Schmermund A, Kahlert P et al (2013) Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): a weighted meta-analysis of 9251 patients from 46 studies. EuroIntervention 8(9):1072–1080. https://doi.org/10.4244/EIJV8I9A164 CrossRefPubMed

23.

Eggebrecht H, Vaquerizo B, Moris C et al (2018) Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI). Eur Heart J 39(8):676–684. https://doi.org/10.1093/eurheartj/ehx713 CrossRefPubMed

24.

Kahlert P, Knipp SC, Schlamann M et al (2010) Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121(7):870–878. https://doi.org/10.1161/CIRCULATIONAHA.109.855866 CrossRefPubMed

25.

Ghanem A, Müller A, Nähle CP et al (2010) Risk and fate of cerebral embolism after transfemoral aortic valve implantation—a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 55(14):1427–1432. https://doi.org/10.1016/j.jacc.2009.12.026 CrossRefPubMed

26.

Kahlert P, Al-Rashid F, Doettger P et al (2012) Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.112.092544 CrossRefPubMed

27.

Sinning JM, Hammerstingl C, Vasa-Nicotera M et al (2012) Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol 59(13):1134–1141. https://doi.org/10.1016/j.jacc.2011.11.048 CrossRefPubMed

28.

Kasel AM, Cassese S, Leber AW et al (2013) Fluoroscopy-guided aortic root imaging for TAVR: “follow the right cusp” rule. JACC Cardiovasc Imaging 6(2):274–275. https://doi.org/10.1016/j.jcmg.2012.06.014 CrossRefPubMed

29.

Grube E, Naber C, Abizaid A et al (2011) Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv 4(7):751–757. https://doi.org/10.1016/j.jcin.2011.03.015 CrossRefPubMed

30.

Mollmann H, Kim WK, Kempfert J et al (2014) Transfemoral aortic valve implantation of Edwards SAPIEN XT without predilatation is feasible. Clin Cardiol 37(11):667–671. https://doi.org/10.1002/clc.22318 CrossRefPubMed

31.

Kim WK, Praz F, Blumenstein J et al (2017) Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation. Catheter Cardiovasc Interv 89(1):E38–E43. https://doi.org/10.1002/ccd.26464 CrossRef

32.

Kim WK, Liebetrau C, Renker M et al (2017) Transfemoral aortic valve implantation using a self-expanding transcatheter heart valve without pre-dilation. Int J Cardiol 243:156–160. https://doi.org/10.1016/j.ijcard.2017.05.092 CrossRefPubMed

33.

Kim WK, Hamm CW (2017) The future of TAVI. Eur Heart J 38(36):2704–2707. https://doi.org/10.1093/eurheartj/ehx474 CrossRefPubMed

Title: Transcatheter aortic valve implantation in Germany
Authors: Won-Keun Kim
Christian W. Hamm
Publication date: 01-08-2018
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue Special Issue 2/2018
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-018-1297-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Transcatheter aortic valve implantation in Germany

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2018

Genetics of coronary artery disease in the light of genome-wide association studies

Therapeutic options in advanced heart failure

Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University

Biomarker in cardiology

LMU Munich: platelet inhibition novel aspects on platelet inhibition and function

Coronary computed tomography angiography: a method coming of age

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page